...
机译:A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk(C481S) mutation in B-cell malignancies
Peking Univ, Sch Basic Med Sci, Inst Syst Biomed, Dept Biophys,Hlth Sci Ctr, Beijing, Peoples R;
Hongyun Biotech Co Ltd, Div Drug Discovery, Nanjing, Jiangsu, Peoples R China;
Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USAShanghai Jiao Tong Univ, Rui Jin Hosp, Natl Res Ctr Translat Med, Shanghai State Key Lab Med GenomXiamen Univ, Innovat Ctr Cell Signaling Network, State Prov Joint Engn Lab Targeted Drugs Nat Prod;